<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02813486</url>
  </required_header>
  <id_info>
    <org_study_id>GC3111_P1/2a</org_study_id>
    <nct_id>NCT02813486</nct_id>
  </id_info>
  <brief_title>Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine</brief_title>
  <official_title>Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Green Cross Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Green Cross Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate safety of GC3111 and to describe immunogenicity of a
      single dose of GC3111 versus Boostrix® vaccine among healthy adults in 19 to &lt;65 years of
      age.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate immunogenicity of GC3111 as tetanus, diphtheria and acellular pertussis (Tdap)
      vaccine in healthy adults.

      To evaluate safety (solicited adverse events) of GC3111 in healthy adults.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Participants With Antibody Responses to Tetanus and Diphtheria Components Following Vaccination With Either GC3111 or Boostrix® Vaccine</measure>
    <time_frame>Day 0 (pre-vaccination) to Day 28 (post-vaccination)</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants Achieving Predefined Antibody Level for Diphtheria, Tetanus, and Acellular Pertussis Antigens</measure>
    <time_frame>28 days after Vaccination</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Geometric Mean Concentrations (GMC) for Diphtheria, Tetanus and Acellular Pertussis Antigens</measure>
    <time_frame>28 days after Vaccination</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Geometric Mean Ratio (GMR) of post-vaccination versus pre-vaccination antibody concentrations against Diphtheria, Tetanus and Acellular Pertussis</measure>
    <time_frame>Day 0 (pre-vaccination) to Day 28 (post-vaccination)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participants Reporting Immediate Solicited Adverse Events Following Vaccination With Either GC3111 or Boostrix® Vaccine</measure>
    <time_frame>Up to 30 minutes post-vaccination</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">220</enrollment>
  <condition>Tetanus</condition>
  <condition>Diphtheria</condition>
  <condition>Whooping Cough</condition>
  <arm_group>
    <arm_group_label>GC3111 Vaccine Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants randomized to receive a single dose of GC3111 vaccine (Biological: GC3111 vaccine).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Boostrix® Vaccine Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants randomized to receive a single dose of Boostrix® vaccine (Biological: Boostrix® vaccine).</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Biological: GC3111 vaccine</intervention_name>
    <description>0.5mL, Intramuscular</description>
    <arm_group_label>GC3111 Vaccine Group</arm_group_label>
    <other_name>GC3111</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Biological: Boostrix® vaccine</intervention_name>
    <description>0.5mL, Intramuscular</description>
    <arm_group_label>Boostrix® Vaccine Group</arm_group_label>
    <other_name>Boostrix®</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy adults aged between 19 and 64 years at the time of vaccination

          -  Informed consent and assent forms have been signed and dated

        Exclusion Criteria:

          -  Known or suspected receipt of any Tdap vaccine

          -  Subject is pregnant, or lactating, or of child bearing potential without using an
             effective method of contraception or not practicing abstinence

          -  Receipt of any vaccine within 30 days before receiving study vaccine

          -  Any condition that, in the opinion of the Investigator, might interfere with the
             ability to comply with trial procedures.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Incheon St. Mary's Hospital Catholic Univ.</name>
      <address>
        <city>Incheon</city>
        <state>Bupyeong 6-dong, Bupyeong-gu,</state>
        <zip>1544-9004</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Catholic Univ. of Korea Daejeon St.Mary's Hospital</name>
      <address>
        <city>Daejeon</city>
        <state>Jung-Gu</state>
        <zip>301-723</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Catholic Univ.of Korea Bucheon St.Mary's Hospital</name>
      <address>
        <city>Gyeonggi-do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Catholic Univ.of Korea Uijeongbu St.Mary's Hospital</name>
      <address>
        <city>Gyeonggi-do</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Catholic Univ.of Korea Yeouido St.Mary's Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 20, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <last_update_submitted>November 4, 2016</last_update_submitted>
  <last_update_submitted_qc>November 4, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tetanus</mesh_term>
    <mesh_term>Tetany</mesh_term>
    <mesh_term>Diphtheria</mesh_term>
    <mesh_term>Whooping Cough</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

